[ABCL] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 181.20%
YoY- 43.81%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 21,545 101,383 45,917 316,581 139,331 5,508 27,643 -15.26%
PBT -31,412 46,587 -6,886 230,809 84,710 -24,972 -2,073 509.32%
Tax -1,519 19,963 -101 62,236 24,762 -3,592 250 -
NP -29,893 26,624 -6,785 168,573 59,948 -21,380 -2,323 446.58%
Tax Rate - -42.85% - -26.96% -29.23% - - -
Total Cost 51,438 74,759 52,702 148,008 79,383 26,888 29,966 43.22%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -138.75 26.26 -14.78 53.25 43.03 -388.16 -8.40 545.28%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.10 0.08 -0.02 0.54 0.21 -0.08 -0.01 362.21%
EPS Diluted -0.10 0.08 -0.02 0.54 0.21 -0.08 -0.01 362.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.